Interview with Dev Ashish Bakshi, Managing Director, Tapasya Engineering Works
One trend we have seen taking place over the years is that, today, Indian machines are far better in quality and in par with international standards, than 15 years ago.…
Address: A-212, Road No30, Wagle Indl. Estate, Thane, India
Tel: 0091 22 25 82 32 50
Web: http://www.tapasyaindia.com/
Our Group of Companies are Manufacturers & Exporters o
People And Enterprises producing extraordinary results dealing powerfully with the challenges of life creating new world of opportunity free from the Constraints of the Past. Pharmaceutical Machineries and Chemical Process Equipments and working in association with Sainath Boilers & Pneumatics.
> Machineries & Equipments for Pharma Industry
> Chemical Plants & Equipments
> Allied Equipments
> Design & Inspection
> Soap Manufacturing Plant and Machinery
One trend we have seen taking place over the years is that, today, Indian machines are far better in quality and in par with international standards, than 15 years ago.…
Ayushman Bharat, launched in 2018, is a monumental scheme addressing the lack of healthcare accessibility and affordability for over 500 million people in India. Dr Indu Bhushan, Ayushman Bharat’s inaugural…
India’s chemical industry is of vital importance to several industries, including pharmaceuticals, and exported USD 30.18 billion worth of products in 2022-23. Chemexcil’s Raghuveer Kini discusses his industry’s key role…
Pratima Reddy, GM at Merck Healthcare India reviews the importance of Merck’s Indian affiliate, discusses the recent reforms that have contributed both to improving patient access and to fostering foreign…
The Indian pharma industry has demonstrated spectacular growth based on its strength as a global generics manufacturer. Yet Indian pharma is not merely resting on its laurels. After shining through…
Sandeep Verma shares his journey of establishing Bayer’s consumer healthcare division in India and reflects on the challenges faced during the division’s inception amidst the COVID-19 pandemic, emphasizing the importance…
India’s pharma industry has big dreams. At the recent Annual Summit of Organisation of Pharmaceutical Producers of India (OPPI) the nation’s policymakers, academicians, industry leaders, innovators, and scientists gathered to…
Peter DeYoung shares the significance of Indian giant Piramal Pharma’s recent demerger from its parent company and its current strategic focus on organic growth, brownfield expansions, and “complex hospital generics.”…
As secretary general of the Indian Pharmaceutical Alliance (IPA) Sudarshan Jain represents the interests of 25 leading Indian pharmaceutical companies, both at home and abroad. He outlines the association’s focus…
The IDMA’s Daara Patel outlines the association’s role in representing the diverse voices of the Indian pharmaceutical sector, advocating for manufacturers of all sizes. He explores the challenges and initiatives…
Indian pharma companies have been building a broader presence in LatAm markets over the past two decades. With well-established trade relations already in place, the region offers a series of unique…
A roundup of some of the top stories from the Indian pharma industry including the suspension of the National Medical Commission’s (NMC) guidelines making the prescription of generic drugs mandatory;…
Top stories from Indian pharma including Sanofi India’s plans to demerge its healthcare businesses; Junshi Biosciences and Dr. Reddy’s anti-PD-1 monoclonal antibody partnership; Venus Remedies’ new oncology approvals; CORONA and…
See our Cookie Privacy Policy Here
